Overview Safety and Efficacy Study of NVC-422 on Bacteriuria in Catheterized Patients Status: Completed Trial end date: 2010-03-01 Target enrollment: Participant gender: Summary The purpose of this clinical trial is to study the effects of NVC-422 instilled into the bladder in reducing bacteria in the urine. Phase: Phase 2 Details Lead Sponsor: NovaBay Pharmaceuticals, Inc.